TechTalks exist to help the park's R&D community connect and start collaborations. Organized by Luris, Leiden Bio Science Park, Boerhaave Nascholing and Centrum Bioscience en Diagnostiek.
Program
- Ex vivo 3D tumor cultures for prediction of treatment response
Dr. Willemijn Vader (founder & CEO, Vitroscan)
- Capturing clinically relevant amounts of circulating tumor cells
Ir. Peter Wiegman (Co-founder & Managing Director, Idris Oncology)
- Wouldn't be that lovely: towards pretreatment knowledge of sensitivity to chemo
Dr. Cor de Kroon (Gynecologic Oncology, LUMC)
- Other speakers still need to be confirmed.
Followed by drinks